JM
Therapeutic Areas
Corline Biomedical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CHS™ Coated Stent | Neurovascular/Peripheral Vascular Disease | Commercial |
| CHS™ Coated Ablation Catheter | Cardiac Arrhythmia | Commercial |
| Renaparin® | Kidney Transplantation | Clinical Development |
| Cytoparin™ | Cell Therapy / Diabetes Type 1 | Research |
| CHC™ | Soft Tissue Repair | Research |
Leadership Team at Corline Biomedical
HN
Henrik Nittmar
Chief Executive Officer
ÅH
Åsa Holm
Chief Operating Officer
AD
Adam Dahlberg
Chairman of the Board
LS
Lars Sunnanväder
Non-Executive Board Member
GE
Gunilla Ekström
Non-Executive Board Member
HK
Henrik Krook
Non-Executive Board Member
MN
Magnus Nilsson
Non-Executive Board Member
RP
Rutger Ploeg
Scientific Advisor